Cargando…
Hypofibrinogenemia induced by high-dose tigecycline—case report and review of literature
RATIONALE: Extensive off-label use may affect the safety profile of tigecycline. Tigecycline-associated hypofibrinogenemia is potentially life threatening, although the frequency of life-threatening reactions is unknown and their incidence is easily overlooked. We report a case of 2 instances of tre...
Autores principales: | Fan, Qiaomei, Huang, Wei, Weng, Yayun, Xie, Xianze, Shi, Zheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7581097/ https://www.ncbi.nlm.nih.gov/pubmed/33120753 http://dx.doi.org/10.1097/MD.0000000000022638 |
Ejemplares similares
-
Efficacy and safety of high-dose tigecycline for the treatment of infectious diseases: A meta-analysis
por: Gong, Jinhong, et al.
Publicado: (2019) -
Risk Factors for Tigecycline-Associated Hypofibrinogenemia
por: Liu, Jia, et al.
Publicado: (2021) -
High-dose tigecycline for the treatment of nosocomial carbapenem-resistant Klebsiella pneumoniae bloodstream infections: A retrospective cohort study
por: Geng, Ting-Ting, et al.
Publicado: (2018) -
Tigecycline-associated hypofibrinogenemia: A case report and review of the literature
por: Wu, Pei-Chun, et al.
Publicado: (2018) -
Clinical study on the safety and efficacy of high-dose tigecycline in the elderly patients with multidrug-resistant bacterial infections: A retrospective analysis
por: Xia, Guolian, et al.
Publicado: (2020)